Tissue-Bonding Technology

Group announces successful cancer surgery using tissue-bonding technology

Published in Gene Therapy Weekly, August 19th, 2004

Consortium Service Management Group, Inc., (CTUM) (CSMG), announced the results of oncological clinical trials in Ukraine using the company's patented live biological tissue-bonding technology.

From April-June 2004, 60 cancer patients were successfully treated in procedures that produced a number of patient benefits including significantly reduced surgical times and reduced blood loss. The trials were conducted under the auspices of the company's subsidiary, Live Tissue Connect.

The trial procedures included:

1) Oncoproctological (26 surgeries) procedures that included excision of excessive relegated colon, formation of intestinal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2004-08-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry